Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Managing placenta accreta spectrum while preserving the uterus

Official title: Uterine Preservation in the Management of Placenta Accreta Spectrum Disorders

Run by University of Pennsylvania · NCT06512181 · Data updated 2026-11-12

This study is testing a new way to manage placenta accreta spectrum disorders by allowing some women to keep their uterus after delivery instead of having surgery, to see if it can be a safer option for them.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment15 (estimated)
SponsorUniversity of Pennsylvania
Academic / other
Locations1 site (Philadelphia, Pennsylvania)
StatusRecruiting
StartedApril 21, 2025
Main results expectedSeptember 1, 2030
Study endsDecember 31, 2030
Registry record updatedMay 11, 2026
Trial IDNCT06512181 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are pregnant women aged 18 or older, between 16-36 weeks gestation, with a history of cesarean delivery and suspected placenta accreta spectrum.

Probably not a fit

Patients with low antenatal suspicion for placenta accreta spectrum based on imaging may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on the conservative management of placenta accreta spectrum disorders, which pose significant risks to maternal health. Instead of the common approach of cesarean-hysterectomy, this pilot study offers selected participants the option to leave the placenta in the uterus after delivery. The study will involve 15 participants who desire uterine preservation and will be monitored during their postpartum stay and through outpatient follow-up until the uterus is empty. This approach aims to provide a safer alternative for women facing this condition.

Why it matters

Potential benefit: If successful, this approach could significantly reduce maternal morbidity and mortality associated with placenta accreta spectrum disorders.

How similar studies have gone: While conservative management approaches have been explored, this specific pilot study represents a novel approach to managing placenta accreta spectrum disorders.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Provision of signed and dated informed consent form.
2. Stated willingness to comply with all study procedures and availability for the duration of the study.
3. A person with a uterus, age 18 or older
4. Currently pregnant with an intrauterine gestation or postpartum
5. Suspected of having PAS based on history, clinical findings, and/or imaging
6. Patients for whom the usual management would be peripartum hysterectomy.
7. Patient desires uterine preservation or declines hysterectomy
8. Agreement to adhere to Lifestyle Considerations (see section 5.3) throughout study duration.

Exclusion Criteria:

• Have a low antenatal suspicion for PAS based on imaging.

Where it's running

  • Hospital of the University of Pennsylvania
    Philadelphia, Pennsylvania, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.